INCR

Intercure Ltd.

• Seeking Alpha·05/01 15:26

  InterCure reports FY results

• TipRanks·05/01 13:49

  InterCure Posts 2025 Revenue Growth, Positive Cash Flow as Recovery and Expansion Accelerate

• PUBT·04/20 20:02

  InterCure files Form 3 as director Alon Shmuel Granot reports initial ownership

• PUBT·04/20 20:02

  InterCure CEO Alexander Rabinovich files initial beneficial ownership statement

• PUBT·04/20 20:01

  InterCure director Lennie Michelson Grinbaum files initial beneficial ownership statement

• PUBT·04/16 20:02

  InterCure files Form 3 for CFO Amos Cohen beneficial ownership stake

• PUBT·04/16 20:01

  InterCure director David Salton files initial beneficial ownership statement

• PUBT·04/16 20:01

  InterCure files Form 3 as director Gideon Hirschfeld reports initial beneficial ownership

• TipRanks·03/03 23:10

  InterCure Faces Nasdaq Compliance Deadline After Bid-Price Breach

• Reuters·03/03 22:07

  Nasdaq Flags InterCure for Minimum Bid Price Noncompliance

• TipRanks·03/03 21:56

  InterCure receives noncompliance notification from Nasdaq

• Benzinga·03/03 21:48

  InterCure Ltd. Receives Nasdaq Non-Compliance Notice, Granted Until August 24, 2026 To Regain Compliance

• Reuters·03/03 21:46

  INTERCURE RECEIVES NASDAQ NOTIFICATION REGARDING MINIMUM BID REQUIREMENT

• TipRanks·02/19 13:01

  InterCure Posts Higher 2025 Revenue and EBITDA, Resumes Nir Oz Output and Advances Expansion Plans

• TipRanks·02/19 12:11

  InterCure reports preliminary FY25 revenue NIS 265M